Vaccine economics don’t pencil out
55:35–55:52 · 17s
Bret and Heather walk through an AI-aided back-of-the-envelope analysis suggesting an mRNA hantavirus vaccine isn’t commercially viable without government purchase and liability shields.
55:35–55:52 · 17s
Bret and Heather walk through an AI-aided back-of-the-envelope analysis suggesting an mRNA hantavirus vaccine isn’t commercially viable without government purchase and liability shields.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.